Blood Mercury: How Much Is Too Much?

What a blood mercury test actually is

Blood mercury measures how much mercury is circulating in your body at the time of the draw — primarily reflecting recent intake over the past several weeks rather than a lifetime logbook. Most people encounter mercury as methylmercury from seafood; that form absorbs efficiently in the gut and partitions into red blood cells, so whole-blood testing captures it well. Inorganic and elemental mercury from occupational or environmental sources also appear in blood, though urine is the preferred matrix for those exposure patterns. Labs typically report "total mercury" in whole blood, which in most non-occupationally exposed people is dominated by the methylmercury fraction.

How methylmercury moves through the body

Methylmercury arrives with a meal, crosses the gut wall efficiently, binds to proteins, and travels in red blood cells to tissues including the brain. The body eliminates it gradually, primarily through bile and stool. Blood half-life is approximately 50–70 days, so levels fall predictably when exposure is reduced. Inorganic and elemental mercury follow different routes — inhaled mercury vapor, for example, enters through the lungs and burdens the kidneys, which is why urine testing is the clearer lens for occupational vapor exposure while blood is the clearer lens for fish-derived methylmercury.

One important limitation: blood mercury does not measure cumulative lifetime body burden. It reflects recent and ongoing exposure, not what has already been deposited in tissues over years. Speciation testing — separating methylmercury from inorganic mercury — can add diagnostic clarity but is not always performed. Additionally, serum underestimates total mercury burden because mercury concentrates in red blood cells; whole blood is the preferred matrix for methylmercury assessment.

Over a lifetime, sustained higher methylmercury exposure is linked to neurodevelopmental effects in children and neurological symptoms in adults at high levels. People who eat fish regularly often benefit from omega-3 fatty acids and favorable dietary patterns; the relevant variable is species selection and frequency, not fish consumption itself. The omega-3 benefit and the methylmercury risk are separable through species choice — smaller, shorter-lived fish tend to deliver the nutrient benefit with lower mercury load.

Reading your blood mercury number in context

Reference intervals are built from population data and tell you what most people's numbers look like, not whether a given value is ideal for a specific individual. Ranges differ by laboratory, geography, and sample matrix, so the numbers below are general orientation points rather than universal cutoffs.

Normal blood mercury

Most U.S. laboratory reference ranges for adults place the upper boundary of normal below 10 mcg/L for whole blood. The CDC's general-population median for non-occupationally exposed adults is approximately 2 mcg/L. The U.S. EPA's risk-based reference value corresponds to roughly 5.8 mcg/L, derived from developmental neurotoxicity data — this is a conservative public-health benchmark, not a hard boundary between safe and unsafe. Sensitive populations, including pregnant individuals and children, may warrant a lower target given the particular vulnerability of the developing nervous system. Because whole blood and serum are not interchangeable, results should always be interpreted using the same matrix; serum can underestimate total burden.

High blood mercury

The most common driver is diet. Large, long-lived predatory fish accumulate more mercury through biomagnification: shark, swordfish, king mackerel, tilefish, and some tuna species — including bigeye tuna — sit at the top of that list. Frequent consumption of these species can elevate blood mercury without necessarily producing symptoms. Occupational and environmental exposures also contribute: dentistry work around amalgams, artisanal gold mining, certain laboratory settings, and handling broken mercury-containing devices can raise levels, though those patterns often show more clearly in urine than blood. If a value is higher than expected, the relevant question is whether it remains elevated on repeat testing after several weeks of reduced high-mercury seafood intake, or whether it falls — the trajectory is informative.

Low blood mercury

A low result typically reflects limited recent exposure — infrequent fish consumption or consistent selection of low-mercury species. Blood mercury also declines over weeks after reducing high-mercury intake, so a falling number after dietary change reflects normal elimination kinetics. Low does not automatically mean optimal from a nutritional standpoint; fatty fish provide omega-3s and protein, and many species deliver those benefits with minimal mercury load. Assay variation matters: whole blood is the preferred matrix, and serum underestimates total burden because mercury concentrates in red cells. If the clinical context is unusual, speciation or repeat testing can clarify the picture.

What drives blood mercury between draws

Exposure source is the primary determinant of blood mercury. Mercury accumulates up the food chain through biomagnification, so species-level accumulation patterns — not cooking methods — determine methylmercury intake. Larger predatory fish at the top of the marine food chain concentrate more mercury; cooking does not remove it because methylmercury is bound within muscle tissue. Raw versus cooked is not the relevant variable; species choice is.

Frequency of consumption compounds the effect. Regular meals of high-mercury species sustain blood levels because new intake arrives before the previous load has fully cleared. Conversely, blood mercury declines over 6–12 weeks after reducing high-mercury fish intake, reflecting the approximately 50–70 day half-life. Occupational exposure adds a separate route: dental, mining, and certain laboratory environments can introduce inorganic or elemental mercury through inhalation or skin contact, shifting the exposure pattern toward forms better captured by urine testing.

Pregnancy context is relevant not because pregnancy changes mercury kinetics dramatically, but because fetal brain development is uniquely sensitive to methylmercury, making the same blood level carry different implications at different life stages. Public health guidance for pregnant individuals emphasizes low-mercury seafood species for this reason.

What about fish oil supplements? Highly purified fish oil products are typically processed to remove contaminants, and mercury levels in such oils are generally negligible. Products that disclose third-party testing provide additional assurance.

Urine, hair, and kidney markers that complete the mercury picture

Blood mercury alone does not distinguish exposure source, assess clearance capacity, or rule out nutrient causes of overlapping symptoms. The following markers add that context:

• Selenium — selenium binds methylmercury in a molar ratio in fish tissues; high-selenium, low-mercury fish species provide the nutrient benefit without the neurotoxic load, making selenium a relevant pairing when interpreting seafood exposure patterns.
• eGFR — kidney function determines mercury clearance rate; reduced eGFR slows elimination and can sustain elevated blood mercury levels even after exposure has been reduced.
• Creatinine — creatinine anchors kidney filtration capacity; an elevated blood mercury alongside falling eGFR or rising creatinine points toward impaired clearance rather than ongoing new exposure.
• Vitamin B12 — B12 deficiency and mercury neurotoxicity share overlapping neurological presentations including cognitive symptoms and peripheral neuropathy; distinguishing the cause requires both markers, and fish is itself a B12 source, making the pairing especially relevant in seafood consumers.
• Folate — folate's neurological role overlaps with mercury symptom presentation; folate and B12 together help rule out nutrient causes of fatigue and cognitive symptoms that may prompt mercury testing in the first place.

Urine mercury pairs with blood mercury to distinguish exposure type: elevated urine with modest blood suggests inorganic or vapor exposure typical of certain occupational settings, while elevated blood with low urine points toward methylmercury from seafood. Hair mercury reflects longer-term methylmercury exposure over months, providing a slower-developing record of dietary pattern that a single blood draw cannot capture.

How fast blood mercury falls after exposure ends

Methylmercury has a blood half-life of approximately 50–70 days. After reducing or eliminating high-mercury fish intake, blood levels fall predictably along that curve. A meaningful reduction is detectable at 8–12 weeks; a full return toward population-median values can take 3–6 months depending on the starting level and the degree of dietary change.

Retest at 8–12 weeks after a sustained dietary change to confirm the trend direction. For comparable results, use the same laboratory and the same matrix — whole blood, not serum — across draws. Draw conditions matter: avoid high-mercury fish in the 24–48 hours before the blood draw, as a single meal of bigeye tuna on the morning of the test can transiently elevate the reading and obscure the underlying trend.

If levels remain elevated after 8–12 weeks of reduced seafood intake, consider whether an occupational or environmental source is contributing — a pattern that urine mercury testing can help clarify.

When a mercury result warrants medical input

Testing turns vague risk into clear data. A result above the laboratory reference range, a value that remains elevated on repeat testing after dietary change, or any result accompanied by neurological symptoms — numbness, tingling, tremor, changes in coordination, or cognitive changes — warrants discussion with a clinician. Pregnant individuals or those planning to conceive should discuss even modestly elevated results given fetal sensitivity to methylmercury. Occupational exposure contexts — dental, mining, laboratory, or industrial settings — add a layer that a clinician familiar with those environments is best placed to interpret, particularly when urine mercury and blood mercury diverge.

For most people with mildly elevated results and no symptoms, the clinical pathway is straightforward: identify the dietary or environmental source, reduce exposure, and confirm the trend with a retest at 8–12 weeks. Chelation therapy is a medical intervention reserved for specific high-exposure situations under clinician oversight and is not a routine response to dietary mercury elevation.

Superpower's approach to biomarker testing — detailed at superpower.com/manifesto — is built around exactly this kind of longitudinal tracking: establishing a baseline, making an informed change, and using a follow-up draw to confirm the response. Mercury sits alongside kidney function, nutrient status, and other markers in a panel that lets you and your clinician read the full picture rather than a single number in isolation. Visit superpower.com to learn more.